Elias Jabbour

Elias Jabbour is a Professor of Medicine at The University of Texas MD Anderson Cancer Center, where he specializes in hematological malignancies, with a focus on leukemia, myeloid neoplasia, and pharmacotherapy. His research centers on the genetic landscape of acute leukemia, including BCL11B rearrangements, and the management of high-risk Philadelphia chromosome-positive acute lymphoblastic leukemia. He has published seminal updates on adult acute lymphoblastic leukemia and chronic myeloid leukemia in JAMA and the American Journal of Hematology. His work also addresses socioeconomic and racial disparities in acute myeloid leukemia treatment outcomes. He is internationally recognized for advancing targeted therapies and clinical trial strategies in leukemia.